標(biāo)題: Titlebook: Colon Cancer Diagnosis and Therapy Vol. 3; Dhananjay Shukla,Naveen Kumar Vishvakarma,Ganji Pu Book 2022 The Editor(s) (if applicable) and [打印本頁] 作者: Defect 時(shí)間: 2025-3-21 17:26
書目名稱Colon Cancer Diagnosis and Therapy Vol. 3影響因子(影響力)
書目名稱Colon Cancer Diagnosis and Therapy Vol. 3影響因子(影響力)學(xué)科排名
書目名稱Colon Cancer Diagnosis and Therapy Vol. 3網(wǎng)絡(luò)公開度
書目名稱Colon Cancer Diagnosis and Therapy Vol. 3網(wǎng)絡(luò)公開度學(xué)科排名
書目名稱Colon Cancer Diagnosis and Therapy Vol. 3被引頻次
書目名稱Colon Cancer Diagnosis and Therapy Vol. 3被引頻次學(xué)科排名
書目名稱Colon Cancer Diagnosis and Therapy Vol. 3年度引用
書目名稱Colon Cancer Diagnosis and Therapy Vol. 3年度引用學(xué)科排名
書目名稱Colon Cancer Diagnosis and Therapy Vol. 3讀者反饋
書目名稱Colon Cancer Diagnosis and Therapy Vol. 3讀者反饋學(xué)科排名
作者: 不怕任性 時(shí)間: 2025-3-21 20:51
Book 2022herapeutic strategies, the five-year survival rate for CRC patients has remained the same over time due to the fact that patients are often diagnosed in advanced metastatic stages. Drug resistance is another common reason for poor prognosis. Researchers are now developing advanced therapeutic strate作者: 進(jìn)取心 時(shí)間: 2025-3-22 04:09
https://doi.org/10.1007/978-3-540-34330-1ently, immunotherapy based on engineered nanoparticles (NP) emerged as a promising approach for CRC treatment. Present review deals with the mechanism, immunology of CRC, and advanced immunotherapy based on nanotechnology.作者: 鉤針織物 時(shí)間: 2025-3-22 05:21 作者: 催眠藥 時(shí)間: 2025-3-22 11:43 作者: 不連貫 時(shí)間: 2025-3-22 16:53 作者: 不連貫 時(shí)間: 2025-3-22 17:08
Therapeutic Intervention of Signaling Pathways in Colorectal Cancer,ies that are specifically directed against cancer cells but have negligible effects on normal cells. In this chapter, we discuss the outcomes of such targeted therapies in colorectal cancer with special emphasis on those developed against cell signaling molecules.作者: Dysarthria 時(shí)間: 2025-3-22 22:29
Role of Food Additives and Intestinal Microflora in Colorectal Cancer, colorectal cancer. The intestinal microflora is also associated with carcinogenesis of CRC. The dysbiosis in gut microbiome due to dietary and environmental changes might be linked with the development and progression of CRC.作者: 縮減了 時(shí)間: 2025-3-23 01:34
Technik der Siedlungsentw?sserungal (25%). The most common genes that are affected in CRC are oncogenes, tumor suppressor genes, and genes related to the DNA repair mechanisms. Structural screening tests (such as colonoscopy, sigmoidoscopy) are superior to stool tests. Studies have shown that colonoscopy has reduced the incidence o作者: 協(xié)迫 時(shí)間: 2025-3-23 08:16
Charakterisierung von Kl?rschlammy multiple molecules and genes are reported to be involved in colon cancer development. Wnt signaling is recognized as a hallmark of colon cancer. It is a critical regulator of the early and late stages of colon cancer metastasis. Emerging studies have suggested that most human genomes have been tra作者: 賭博 時(shí)間: 2025-3-23 10:27 作者: creatine-kinase 時(shí)間: 2025-3-23 14:09
Schmutzstoffanfall und Temperaturence of CC include modifiable and nonmodifiable risk factors. Notably, the genetic risk factors play a crucial role in developing . to CC. The molecular heterogeneity of CC also remains a significant and crucial aspect for personalized therapy. Therefore, detecting suitable molecular genetic biomark作者: 琺瑯 時(shí)間: 2025-3-23 20:15
https://doi.org/10.1007/978-3-540-34330-1ith the immune system, play a role in CRC’s development and progression. Its high prevalence and mortality rate demand early detection and efficient treatment strategies. Though traditional therapeutic approaches such as surgery, radiotherapy, and chemotherapy are used in CRC treatment, they are lim作者: Sigmoidoscopy 時(shí)間: 2025-3-23 23:22 作者: GLARE 時(shí)間: 2025-3-24 02:25
Charakterisierung von Kl?rschlammcerous cells are also eliminated, resulting in systemic, undesirable side effects and poor quality of patient life. Advancement in molecular techniques and massively parallel sequencing strategies has led to better patient stratification and the discovery of unique patient-/cancer-specific molecular作者: jaunty 時(shí)間: 2025-3-24 09:05 作者: 某人 時(shí)間: 2025-3-24 13:51 作者: START 時(shí)間: 2025-3-24 18:07 作者: 極端的正確性 時(shí)間: 2025-3-24 19:53 作者: 白楊魚 時(shí)間: 2025-3-25 00:16 作者: NAVEN 時(shí)間: 2025-3-25 06:44 作者: Bucket 時(shí)間: 2025-3-25 11:06 作者: 嬉耍 時(shí)間: 2025-3-25 13:33
Automorphism groups of bilinear forms, experimental evidence suggest that bacteria and their products can be implemented for therapeutic benefit in malignant disorders including those of colon origin. The use of bacteria or their components for antineoplastic therapy is known as bacterial cancer therapy. Limitations associated with conv作者: hazard 時(shí)間: 2025-3-25 16:12
The fundamental domain of the modular group,y and antineoplastic activities against malignancies of a variety of origins. Colorectal cancer is one of the major deadly malignancies. Various strategies have been implemented to treat colorectal cancer; however, they have their own limitations, ranging from nonspecific toxicities to onset of chem作者: Bravura 時(shí)間: 2025-3-25 21:24
Siegel‘s Modular Forms and Dirichlet Seriesin organs such as the lymph nodes, bone marrow, liver, and lungs. These are upregulated when normal colonic mucosa becomes cancerous and the cancer becomes more malignant as in the case of CRC. In the last few decades, it has emerged that chemokine and their receptor system represent a potential tar作者: Pcos971 時(shí)間: 2025-3-26 02:31 作者: 小畫像 時(shí)間: 2025-3-26 06:06
http://image.papertrans.cn/c/image/229658.jpg作者: JOT 時(shí)間: 2025-3-26 11:29 作者: 打包 時(shí)間: 2025-3-26 12:37
The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Switzerl作者: insipid 時(shí)間: 2025-3-26 20:51 作者: 絆住 時(shí)間: 2025-3-27 00:36 作者: legislate 時(shí)間: 2025-3-27 04:46 作者: Connotation 時(shí)間: 2025-3-27 09:22 作者: Myelin 時(shí)間: 2025-3-27 11:35
Charakterisierung von Kl?rschlammchapter discusses phytochemical therapeutics for targeting Wnt pathway-related lncRNAs in colon cancer. In conclusion, Wnt pathway-related lncRNAs that modulate the diverse mechanisms of drug resistance and metastatic ability of colon cancer are potential targets of phytochemical therapeutics.作者: 一起 時(shí)間: 2025-3-27 17:32 作者: macular-edema 時(shí)間: 2025-3-27 20:24
Schmutzstoffanfall und Temperaturficant genetic variants associated with CC based on the existing data. As suggested from the previous studies, the gene SNPs (., ., ., ., ., ., ., .) are associated with colon cancer. The miRNA SNPs (rs8905 (PRKAR1A), rs8176318 (BRCA1)) and miRNA target SNPs as well (rs8905 (PRKAR1A), rs8176318 (BRC作者: eardrum 時(shí)間: 2025-3-27 22:40 作者: 鍍金 時(shí)間: 2025-3-28 04:13 作者: 膠狀 時(shí)間: 2025-3-28 08:27 作者: Apoptosis 時(shí)間: 2025-3-28 12:15
https://doi.org/10.1007/978-3-642-51729-7their immunomodulatory properties modulate cytokine and chemokine production and activate immune cells. Experimental studies suggest their cytotoxic capability and role in chemoprevention of colorectal cancer cells. They play chief role in the activation of guardian gene p53 in human body, modificat作者: brother 時(shí)間: 2025-3-28 15:00 作者: falsehood 時(shí)間: 2025-3-28 20:12 作者: 幼兒 時(shí)間: 2025-3-29 01:54 作者: accordance 時(shí)間: 2025-3-29 03:57 作者: 調(diào)情 時(shí)間: 2025-3-29 09:31 作者: Override 時(shí)間: 2025-3-29 11:44
Mechanistic Exploration and Therapeutic Management of Colon Cancer Metastasis,作者: FUSE 時(shí)間: 2025-3-29 16:42 作者: 爭論 時(shí)間: 2025-3-29 23:23
Updates on Clinical Trials in Diagnosis and Therapy of Colorectal Cancer,r adjuvant chemotherapy are FOLFOX (5-FU/LV/Oxaliplatin) or capecitabine/LV/oxaliplatin. Palliative chemotherapy options involve 5-FU with leucovorin, capecitabine alone, FOLFOX or FOLFIRI regiments (5-FU/LV/irinotecan). Efficacy of combination regimens are enhanced by the use of monoclonal antibodi作者: Capture 時(shí)間: 2025-3-30 01:56
Wnt Signaling-Related Long Noncoding RNAs: Critical Mediators of Drug Resistance in Colon Cancer,chapter discusses phytochemical therapeutics for targeting Wnt pathway-related lncRNAs in colon cancer. In conclusion, Wnt pathway-related lncRNAs that modulate the diverse mechanisms of drug resistance and metastatic ability of colon cancer are potential targets of phytochemical therapeutics.作者: SPALL 時(shí)間: 2025-3-30 06:59
The Triad of Estrogen, Estrogen Receptors, and Colon Cancer,Interestingly, hormone replacement therapy with estrogen is proven to reduce the risk of colorectal cancer (CRC) in postmenopausal women. Estrogen exerts its action by binding with nuclear receptors ERα and ERβ and also through binding with the membrane bound G-protein coupled estrogen receptor (GPE作者: FLIP 時(shí)間: 2025-3-30 09:46
Clinical Significance of Genetic Variants in Colon Cancer,ficant genetic variants associated with CC based on the existing data. As suggested from the previous studies, the gene SNPs (., ., ., ., ., ., ., .) are associated with colon cancer. The miRNA SNPs (rs8905 (PRKAR1A), rs8176318 (BRCA1)) and miRNA target SNPs as well (rs8905 (PRKAR1A), rs8176318 (BRC作者: palette 時(shí)間: 2025-3-30 16:00 作者: Enzyme 時(shí)間: 2025-3-30 19:18 作者: 不適當(dāng) 時(shí)間: 2025-3-30 23:56 作者: 連詞 時(shí)間: 2025-3-31 01:55 作者: Commonwealth 時(shí)間: 2025-3-31 06:44
Prevention and Management of Colon Cancer by Nutritional Intervention,spices, etc., have lower risk of colon cancer. Bioactive components present in various diet play a significant role in decreasing the risk of colon cancer. These bioactive components have antioxidant, antiproliferative, anti-inflammatory, and proapoptotic activity which together fight against colon 作者: 洞穴 時(shí)間: 2025-3-31 11:00
Effect of Milk and Dairy Products in Colorectal Cancer, effect has been observed for milk, calcium, and vitamin D, when consumed both alone or in combination. Casein and whey proteins and their hydrolysates in the form of bioactive peptides offer protection against CRC. Whey proteins and their derivatives are also being used because they improve body co作者: 迅速成長 時(shí)間: 2025-3-31 13:30 作者: investigate 時(shí)間: 2025-3-31 19:29 作者: BOOR 時(shí)間: 2025-3-31 23:33 作者: FORGO 時(shí)間: 2025-4-1 03:47 作者: 食料 時(shí)間: 2025-4-1 07:07 作者: expire 時(shí)間: 2025-4-1 13:49
Wnt Signaling-Related Long Noncoding RNAs: Critical Mediators of Drug Resistance in Colon Cancer,y multiple molecules and genes are reported to be involved in colon cancer development. Wnt signaling is recognized as a hallmark of colon cancer. It is a critical regulator of the early and late stages of colon cancer metastasis. Emerging studies have suggested that most human genomes have been tra
